ClinicalTrials.gov

History of Changes for Study: NCT04340843
Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma
Latest version (submitted September 15, 2021) on ClinicalTrials.gov
  • A study version is represented by a row in the table.
  • Select two study versions to compare. One each from columns A and B.
  • Choose either the "Merged" or "Side-by-Side" comparison format to specify how the two study versions are to be displayed. The Side-by-Side format only applies to the Protocol section of the study.
  • Click "Compare" to do the comparison and show the differences.
  • Select a version's Submitted Date link to see a rendering of the study for that version.
  • The yellow A/B choices in the table indicate the study versions currently compared below. A yellow table row indicates the study version currently being viewed.
  • Hover over the "Recruitment Status" to see how the study's recruitment status changed.
  • Study edits or deletions are displayed in red.
  • Study additions are displayed in green.
Study Record Versions
Version A B Submitted Date Changes
1 April 9, 2020 None (earliest Version on record)
2 April 14, 2020 Study Status
3 April 22, 2020 Study Status
4 May 2, 2020 Study Status
5 July 3, 2020 Study Status
6 August 27, 2020 Recruitment Status, Study Status, Outcome Measures, Contacts/Locations, Eligibility, Study Description and Oversight
7 September 10, 2020 Contacts/Locations, Eligibility, Study Status and Study Identification
8 September 18, 2020 Study Status
9 September 19, 2020 Contacts/Locations and Study Status
10 October 1, 2020 Contacts/Locations and Study Status
11 October 9, 2020 Study Status
12 October 13, 2020 Contacts/Locations and Study Status
13 November 4, 2020 Contacts/Locations and Study Status
14 November 17, 2020 Contacts/Locations and Study Status
15 November 19, 2020 Study Status
16 November 26, 2020 Contacts/Locations and Study Status
17 December 2, 2020 Contacts/Locations and Study Status
18 December 10, 2020 Eligibility, Outcome Measures, Study Description and Study Status
19 December 15, 2020 Conditions and Study Status
20 December 22, 2020 Contacts/Locations and Study Status
21 December 30, 2020 Arms and Interventions and Study Status
22 January 5, 2021 Recruitment Status, Study Status and Contacts/Locations
23 January 6, 2021 Study Status
24 January 8, 2021 Recruitment Status, Study Status and Contacts/Locations
25 January 28, 2021 Recruitment Status, Study Status and Contacts/Locations
26 January 29, 2021 Study Status
27 February 27, 2021 Arms and Interventions, Study Description and Study Status
28 April 13, 2021 Arms and Interventions and Study Status
29 May 4, 2021 Arms and Interventions and Study Status
30 June 16, 2021 Study Status
31 July 2, 2021 Study Status
32 July 28, 2021 Study Status
33 August 20, 2021 Recruitment Status, Arms and Interventions, Study Status, Contacts/Locations, Study Description, Study Identification, Eligibility, Outcome Measures and Study Design
34 September 7, 2021 Contacts/Locations and Study Status
35 September 9, 2021 Contacts/Locations and Study Status
36 September 14, 2021 Contacts/Locations and Study Status
37 September 15, 2021 Contacts/Locations and Study Status
Comparison Format:

U.S. National Library of Medicine | U.S. National Institutes of Health | U.S. Department of Health & Human Services